Profiles: Page 2
The latest opinion pieces by industry thought leaders
-
Harnessing the creative energy of California, Alto is advancing a novel approach to psychiatric meds
After making the leap from academia to the world of biotech, CEO Dr. Amit Etkin is hoping to shift the treatment paradigm for neurological conditions.
Alexandra Pecci • Oct. 11, 2022 -
Red Jacket: Jim Lang
The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.
PharmaVoice staff • Sept. 15, 2022 -
Red Jacket: Peyton Howell
The chief operating and growth officer of Parexel has sold her market access company and created award-winning DE&I programs, but it’s her role as “connector” that she takes the greatest pride in.
PharmaVoice staff • Sept. 15, 2022 -
Red Jacket: Quita Highsmith
The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.
PharmaVoice staff • Sept. 15, 2022 -
Red Jacket: Fabio Gratton
The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.
PharmaVoice staff • Sept. 15, 2022 -
Red Jacket: Udit Batra
A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.”
PharmaVoice staff • Sept. 15, 2022 -
Disrupters: Dr. Yvonne Greenstreet
The CEO of Alnylam — a leader in RNAi therapies — has the company at the top of its game scientifically and culturally.
PharmaVoice staff • Sept. 6, 2022 -
Entrepreneurs: WeiQing Zhou
The COO has launched two jewels in the biotech world that complement each other while serving broader innovation goals throughout the industry.
Meagan Parrish • Sept. 6, 2022 -
Entrepreneurs: Vincent Keunen
With his unique platform, the has built a bridge between patients, physicians and researchers around the world.
Meagan Parrish • Sept. 6, 2022 -
Disrupters: Trishna Bharadia
As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.
Alexandra Pecci • Sept. 6, 2022 -
Disrupters: Dr. Tania Small
GSK’s medical oncology head is paving the way for patient-driven drug development and more equitable care.
PharmaVoice staff • Sept. 6, 2022 -
Legacy Leaders: Dr. Steven Steinhubl
The chief medical officer at physIQ is working at the intersection of healthcare, clinical trials and technology to deliver better, faster and more accurate treatments to patients around the globe.
Karissa Waddick • Sept. 6, 2022 -
Innovators: Dr. Stephen Dale
The CMO at Kura Oncology, a clinical-stage biopharma company, is charting a new course to deliver on the promise of precision medicine in oncology.
PharmaVoice staff • Sept. 6, 2022 -
Disrupters: Simba Gill
The CEO of Evelo Biosciences is going where no one else in biotech has gone before.
Meagan Parrish • Sept. 6, 2022 -
Innovators: Shanthi Ganeshan
The longtime regulatory pro has used innovative strategies to deliver emerging oncology therapies to patients from her position as head of regulatory affairs at Stemline.
Meagan Parrish • Sept. 6, 2022 -
DE&I Champions: Sebastian Guth
Bayer Pharmaceuticals’ president, Americas Region, is driving equality efforts both within the company and for patients.
PharmaVoice staff • Sept. 6, 2022 -
DE&I Champions: Scott Gray
The CEO, founder and president of Clincierge is championing diversity and inclusion within the company and beyond.
Meagan Parrish • Sept. 6, 2022 -
Tech Wizards: Sastry Chilukuri
The co-CEO of Medidata is ushering in the next generation of clinical trial advancements, making research easier and more patient-focused than ever before.
PharmaVoice staff • Sept. 6, 2022 -
Innovators: Sarah Hersey
At Bristol Myers Squibb, Sarah Hersey challenges the norm — and herself — to continually bring the best solutions to patients as vice president of translational sciences and diagnostics.
Alexandra Pecci • Sept. 6, 2022 -
Disrupters: Samantha Singer
Abata’s CEO is stepping into the ring to fight for patients with progressive MS and other autoimmune disorders.
PharmaVoice staff • Sept. 6, 2022 -
Disrupters: Sally Allain
The newest location for Johnson & Johnson Innovation’s incubator JLABS is in Washington, D.C., and the head of the cutting-edge space is bringing a diverse set of disruptive companies together.
Michael Gibney • Sept. 6, 2022 -
Disrupters: Rosalind Brewer
The CEO of Walgreens Boots Alliance is transforming the pharmacy powerhouse into a major new player in the healthcare space.
PharmaVoice staff • Sept. 6, 2022 -
Tech Wizards: Dr. Rich Christie
Driven by an enthusiasm for invention and a connection between scientific expertise and patient outcomes, the AiCure chief medical officer looks to nurture AI-powered technology.
PharmaVoice staff • Sept. 6, 2022 -
DE&I Champions: Renata Campos
Takeda's Growth and Emerging Markets Business Unit president is driving growth by doing what’s right for patients and her teams.
PharmaVoice staff • Sept. 6, 2022 -
Legacy Leaders: Raymond Stevens
The longtime pioneer in new drug discovery methods and founder of Structure Therapeutics has leveraged innovative science for commercial success.
Meagan Parrish • Sept. 6, 2022